Evidence map›Paper›PMID 35304101›Full record

ArticleThe Journal of biological chemistry2022

Periosteum-derived podoplanin-expressing stromal cells regulate nascent vascularization during epiphyseal marrow development.

Shogo Tamura, Masato Mukaide, Yumi Katsuragi, Wataru Fujii, Koya Odaira, Nobuaki Suzuki, Nagaharu Tsukiji, Shuichi Okamoto, Atsuo Suzuki, Takeshi Kanematsu and 9 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Shogo TamuraDepartment of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: stamura@met.nagoya-u.ac.jp.
Masato MukaideDepartment of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yumi KatsuragiDepartment of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Wataru FujiiDepartment of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Koya OdairaDepartment of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nobuaki SuzukiDepartment of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.
Nagaharu TsukijiDepartment of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Shuichi OkamotoDepartment of Clinical Laboratory, Nagoya University Hospital, Nagoya, Japan.
Atsuo SuzukiDepartment of Medical Technique, Nagoya University Hospital, Nagoya, Japan.
Takeshi KanematsuDepartment of Clinical Laboratory, Nagoya University Hospital, Nagoya, Japan.
Akira KatsumiDepartment of Hematology, National Center for Geriatrics and Gerontology, Obu City, Japan.
Akira TakagiDepartment of Medical Technology, Shubun University, Ichinomiya, Japan.
Katsuhide IkedaDepartment of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Jun UeyamaDepartment of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Masaaki HirayamaDepartment of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Katsue Suzuki-InoueDepartment of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Tadashi MatsushitaDepartment of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan; Department of Clinical Laboratory, Nagoya University Hospital, Nagoya, Japan.
Tetsuhito KojimaDepartment of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan; Aichi Health Promotion Foundation, Nagoya, Japan.
Fumihiko HayakawaDepartment of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nagoya University · JPNagoya University Hospital · JPUniversity of Yamanashi · JPAichi Health Promotion Foundation · JPNational Center for Geriatrics and Gerontology · JPShubun University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone marrow development and endochondral bone formation occur simultaneously. During endochondral ossification, periosteal vasculatures and stromal progenitors invade the primary avascular cartilaginous anlage, which induces primitive marrow development. We previously determined that bone marrow podoplanin (PDPN)-expressing stromal cells exist in the perivascular microenvironment and promote megakaryopoiesis and erythropoiesis. In this study, we aimed to examine the involvement of PDPN-expressing stromal cells in postnatal bone marrow generation. Using histological analysis, we observed that periosteum-derived PDPN-expressing stromal cells infiltrated the cartilaginous anlage of the postnatal epiphysis and populated on the primitive vasculature of secondary ossification center. Furthermore, immunophenotyping and cellular characteristic analyses indicated that the PDPN-expressing stromal cells constituted a subpopulation of the skeletal stem cell lineage. In vitro xenovascular model cocultured with human umbilical vein endothelial cells and PDPN-expressing skeletal stem cell progenies showed that PDPN-expressing stromal cells maintained vascular integrity via the release of angiogenic factors and vascular basement membrane-related extracellular matrices. We show that in this process, Notch signal activation committed the PDPN-expressing stromal cells into a dominant state with basement membrane-related extracellular matrices, especially type IV collagens. Our findings suggest that the PDPN-expressing stromal cells regulate the integrity of the primitive vasculatures in the epiphyseal nascent marrow. To the best of our knowledge, this is the first study to comprehensively examine how PDPN-expressing stromal cells contribute to marrow development and homeostasis.

Indexed as

Bone MarrowPeriosteumEndothelial CellsHumansHuman Umbilical Vein Endothelial CellsMembrane GlycoproteinsStromal CellsMembrane Glycoproteinsangiogenesisbone marrow developmentflow cytometryimmunohistochemistryNotch pathwaypodoplanin-expressing stromal cellsecondary ossification centerskeletal stem cellvasculogenesis

Identifiers

PMID35304101
PMCPMC9019254
OpenAlexW4220926455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.